TCG Crossover Management LLC 13D and 13G filings for Tyra Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-09-29 06:01 am Unchanged | 2021-09-15 | 13G | Tyra Biosciences, Inc. TYRA | TCG Crossover Management LLC | 937,500 2.200% | 0 (Unchanged) | Filing |
| 2021-09-21 12:16 pm Purchase | 2021-09-15 | 13G | Tyra Biosciences, Inc. TYRA | TCG Crossover Management LLC | 937,500 8.700% | 937,500 (New Position) | Filing |